- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/65 - Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
Patent holdings for IPC class A61K 47/65
Total number of patents in this class: 1605
10-year publication summary
|
50
|
65
|
123
|
210
|
211
|
199
|
198
|
213
|
229
|
54
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19661 |
29 |
| SeaGen Inc | 572 |
25 |
| Daiichi Sankyo Company, Limited | 1855 |
23 |
| Bayer Pharma AG | 1058 |
20 |
| Bicyclerd Limited | 142 |
17 |
| CytomX Therapeutics, Inc. | 215 |
15 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 615 |
15 |
| SynDevRx, Inc. | 45 |
15 |
| Genentech, Inc. | 3888 |
14 |
| MedImmune Limited | 598 |
14 |
| Genequantum Healthcare (Suzhou) Co., Ltd. | 57 |
13 |
| Cornell University | 3252 |
12 |
| ImmunoGen, Inc. | 400 |
12 |
| Bristol-myers Squibb Company | 4848 |
11 |
| The Johns Hopkins University | 5568 |
11 |
| Duke University | 3035 |
10 |
| Purdue Research Foundation | 3523 |
10 |
| Blaze BioScience, Inc. | 77 |
10 |
| Case Western Reserve University | 1776 |
10 |
| Immunwork Inc. | 25 |
10 |
| Other owners | 1309 |